More studies are needed to identify the kinetics of JAK–STAT activation in cells involved in regulating thrombosis, and the impact of JAK–STAT inhibition on inflammatory and thrombotic manifestations in COVID-19 patients. This evidence concerns the gene SOAT1 and COVID-19.